Dihydrodiol-Ibrutinib
Dihydrodiol-Ibrutinib (PCI-45227) is a dihydrodiol active metabolite of Ibrutinib (HY-10997), has inhibitory activity towards BTK approximately 15 times lower than that of ibrutinib[1].
Product Specifications
CAS Number
[1654820-87-7]
Product Name Alternative
PCI-45227
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pci-45227.html
Purity
99.91
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)C(O)CO
Molecular Formula
C25H26N6O4
Molecular Weight
474.51
Precautions
H302, H315, H319, H335
References & Citations
[1]Sridhar Veeraraghavan, et al. Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study. J Pharm Biomed Anal
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA507020S 30 µL
CYBC1 Mouse Monoclonal Antibody [Clone ID: OTI3F10]
Sign In for Pricing
View Details 
JH914775 1 Each
Methyl 6-chloro-1H-pyrazolo[3,4-b]pyridine-3-carboxylate
Sign In for Pricing
View Details